13FAI ai-powered hedge fund tracker

Novartis AG (NVS) — Hedge Fund Ownership Q1 2026

NVS
Q1 2026Q4 2025Q3 2025Q2 2025
  • Novartis AG (NVS) is held by 5 of 82 tracked hedge funds, with Tweedy, Browne (1%) and Dodge & Cox (1%) holding the largest stakes, indicating limited hedge fund interest relative to peers.
  • The biggest increases in NVS holdings came from Maverick Capital (+38%), highlighting conviction.
  • The biggest decreases in NVS holdings came from Dodge & Cox (-23%) and Tweedy, Browne (-5%), suggesting profit-taking or de-risking.
  • 2 hedge funds exited NVS.
  • Overall, hedge funds decreased exposure to Novartis AG (NVS) by -23% vs the prior quarter and -41% vs prior year.
# Fund % of Portfolio † Shares † Shares vs Prior Quarter † Shares vs Prior Year † Aggregate Value † Reported Price * Option
1
Tweedy, Browne
Tweedy, Browne Co LLC
0.87% 71K -4.81% -12.00% $10.9M $152.75
2
Dodge & Cox
0.58% 7.0M -22.71% -41.04% $1.06B $152.75
3
Kahn Brothers Group
Irving Kahn
0.36% 13K -2.13% -38.90% $2.0M $152.75
4
Maverick Capital
Lee Ainslie
0.03% 15K +37.70% $2.3M $152.75
5
Causeway Capital Management
0.00% 1K -23.15% -64.90% $227,167 $152.77
Mairs & Power
EXITED
Third Avenue Management
EXITED
5 Total 7.1M -23.10% -41.25% $1.08B
* Reported price is not an actual purchase or sale price. It is the price as of the last portfolio date.
† Portfolio value, share counts, and period-over-period changes exclude options positions (PUT/CALL), which are shown in the Option column for reference only.